Rui Gong

2.1k total citations
88 papers, 1.5k citations indexed

About

Rui Gong is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Rui Gong has authored 88 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 29 papers in Radiology, Nuclear Medicine and Imaging and 26 papers in Infectious Diseases. Recurrent topics in Rui Gong's work include Monoclonal and Polyclonal Antibodies Research (25 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Glycosylation and Glycoproteins Research (15 papers). Rui Gong is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (25 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Glycosylation and Glycoproteins Research (15 papers). Rui Gong collaborates with scholars based in China, United States and Macao. Rui Gong's co-authors include Dimiter S. Dimitrov, Yang Feng, Tianlei Ying, Weizao Chen, Chao Yang, Ponraj Prabakaran, Xinyu Gao, Qi Zhao, Haiwei Zhang and Gengfu Xiao and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Rui Gong

81 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Gong China 23 719 595 380 257 201 88 1.5k
Laura J. Peek United States 15 650 0.9× 359 0.6× 170 0.4× 478 1.9× 105 0.5× 30 1.5k
Daniel I. R. Spencer United Kingdom 23 1.3k 1.7× 471 0.8× 176 0.5× 448 1.7× 147 0.7× 72 1.9k
Richard A. Urbanowicz United Kingdom 24 281 0.4× 303 0.5× 312 0.8× 246 1.0× 432 2.1× 50 1.5k
Sarah S. Wilson United States 18 805 1.1× 112 0.2× 222 0.6× 391 1.5× 376 1.9× 24 1.7k
Babita Agrawal Canada 26 865 1.2× 324 0.5× 300 0.8× 848 3.3× 339 1.7× 65 1.9k
Patrick H.C. van Berkel Netherlands 22 1.2k 1.7× 800 1.3× 212 0.6× 460 1.8× 85 0.4× 27 2.5k
Kenny Roose Belgium 25 958 1.3× 442 0.7× 711 1.9× 841 3.3× 903 4.5× 37 2.3k
S. Garforth United States 19 635 0.9× 125 0.2× 404 1.1× 625 2.4× 248 1.2× 44 1.7k
Naveenchandra Suryadevara United States 14 455 0.6× 171 0.3× 909 2.4× 381 1.5× 151 0.8× 25 1.4k
François Helle France 26 430 0.6× 380 0.6× 503 1.3× 170 0.7× 1.0k 5.0× 64 2.3k

Countries citing papers authored by Rui Gong

Since Specialization
Citations

This map shows the geographic impact of Rui Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Gong more than expected).

Fields of papers citing papers by Rui Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Gong. The network helps show where Rui Gong may publish in the future.

Co-authorship network of co-authors of Rui Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Gong. A scholar is included among the top collaborators of Rui Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Gong. Rui Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hu, Hengrui, Chengcheng Leng, Peng Lü, et al.. (2025). Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2. Journal of Virology. 99(2). e0130724–e0130724.
3.
Zhou, Jinge, Kaiyue Zhang, Yuping Wang, et al.. (2024). Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Reports. 43(6). 114269–114269. 20 indexed citations
4.
Zhou, Jinge, Yun Yang, Entao Li, et al.. (2024). Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Molecular Therapy. 32(6). 1779–1789. 37 indexed citations
5.
Fang, Xueyang, Rui Gong, Decai Yang, et al.. (2024). NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. Journal of the American Chemical Society. 146(22). 15251–15263. 37 indexed citations
6.
Zhang, Huajun, Yanfeng Yao, Ming Li, et al.. (2024). Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains. Nature Communications. 15(1). 2987–2987. 13 indexed citations
7.
Zhang, Xiaoxu, Jie Zhong, Rui Gong, et al.. (2024). PHDtools: A platform for pathogen detection and multi-dimensional genetic signatures decoding to realize pathogen genomics data analyses online. Gene. 909. 148306–148306. 3 indexed citations
8.
Chen, Shaohong, Xinghai Zhang, Yanfeng Yao, et al.. (2024). Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. Virologica Sinica. 39(6). 909–916. 5 indexed citations
9.
Wu, Yan, Hongqing Zhang, Hongqing Zhang, et al.. (2024). A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice. Journal of Medical Virology. 96(12). e70134–e70134. 1 indexed citations
10.
Li, Weiqing, et al.. (2024). Quality of evidence supporting the role of probiotics for rheumatoid arthritis: an overview of systematic reviews. Frontiers in Immunology. 15. 1397716–1397716. 2 indexed citations
11.
Zhang, Xinghai, Huajun Zhang, Tingting Li, et al.. (2022). A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery. Signal Transduction and Targeted Therapy. 7(1). 301–301. 10 indexed citations
12.
Zhou, Shihao, Haiwei Zhang, Yanling Liu, et al.. (2022). RBD conjugate vaccine with a built-in TLR1/2 agonist is highly immunogenic against SARS-CoV-2 and variants of concern. Chemical Communications. 58(13). 2120–2123. 22 indexed citations
13.
14.
Li, Xiyang, Lu Wang, Haiwei Zhang, et al.. (2022). Structural basis of nanobodies neutralizing SARS-CoV-2 variants. Structure. 30(5). 707–720.e5. 14 indexed citations
15.
Zhang, Huajun, Xing‐Lou Yang, Haiwei Zhang, et al.. (2021). Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics. Nature Communications. 12(1). 16 indexed citations
16.
Ma, Fuying, Zherui Zhang, Mingxin Li, et al.. (2020). Vaccination with Consensus H7 Elicits Broadly Reactive and Protective Antibodies against Eurasian and North American Lineage H7 Viruses. Vaccines. 8(1). 143–143. 5 indexed citations
17.
Yang, Chao, Xinyu Gao, Xuan Li, et al.. (2019). Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design. Journal of Biological Chemistry. 294(27). 10638–10648. 9 indexed citations
18.
Wang, Ying, Yaming Shan, Xinyu Gao, et al.. (2018). Screening and expressing HIV-1 specific antibody fragments in Saccharomyces cerevisiae. Molecular Immunology. 103. 279–285. 6 indexed citations
19.
Peng, Xiaoxue, Ji‐An Pan, Rui Gong, et al.. (2006). Functional Characterization of Syncytin-A, a Newly Murine Endogenous Virus Envelope Protein. Journal of Biological Chemistry. 282(1). 381–389. 12 indexed citations
20.
Gong, Rui, Xiaoxue Peng, Shuli Kang, et al.. (2005). Structural characterization of the fusion core in syncytin, envelope protein of human endogenous retrovirus family W. Biochemical and Biophysical Research Communications. 331(4). 1193–1200. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura J. Peek Breakdown of academic impact, for papers by Daniel I. R. Spencer Breakdown of academic impact, for papers by Richard A. Urbanowicz Breakdown of academic impact, for papers by Sarah S. Wilson Breakdown of academic impact, for papers by Babita Agrawal Breakdown of academic impact, for papers by Patrick H.C. van Berkel Breakdown of academic impact, for papers by Kenny Roose Breakdown of academic impact, for papers by S. Garforth Breakdown of academic impact, for papers by Naveenchandra Suryadevara Breakdown of academic impact, for papers by François Helle
Rankless by CCL
2026